Opiate screening and quantitation in urine/blood matrices using LC-MS/MS techniques

Methods in Molecular Biology

Volumn 902, Issue , 2012, Pages 53-64

  Eichhorst, Jeff C ^a   Etter, Michele L ^a   Hall, Patricia L ^a   Lehotay, Denis C ^a  

^a Saskatchewan Disease Control Laboratory   (Canada)

Author keywords

Chromatography; GC MS; LC MS MS; Opiates; Opioids; Screening; Tandem mass spectrometry; Toxicology

Indexed keywords

NARCOTIC ANALGESIC AGENT;

BLOOD; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HIGH THROUGHPUT SCREENING; HUMAN; METABOLISM; REVIEW; SENSITIVITY AND SPECIFICITY; SOLID PHASE EXTRACTION; TANDEM MASS SPECTROMETRY; URINE;

ANALGESICS, OPIOID; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HIGH-THROUGHPUT SCREENING ASSAYS; HUMANS; SENSITIVITY AND SPECIFICITY; SOLID PHASE EXTRACTION; TANDEM MASS SPECTROMETRY;

EID: 84865316049     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-61779-934-1_5     Document Type: Review

References (14)

1. Gergov M, Nokua P, Vuori E, Ojanpera I (2009) Simultaneous screening and quanti fi cation of 25 opioid drugs in post-mortem blood and urine by liquid chromatography-tandem mass spectrometry. Forensic Sci Int 186:36-43
2. Kushnir MM, Rockwood AL, Nelson GJ, Yue B, Urry FM (2005) Assessing analytical speci fi city in quantitative analysis using tandem mass spectrometry. Clin Biochem 38:319-327
3. Maralikova B, Weinmann W (2004) Con fi rmatory analysis for drugs of abuse in plasma and urine by high-performance liquid chromatography-tandem mass spectrometry with respect to criteria for compound identi fi cation. J Chromatogr B: Analyt Technol Biomed Life Sci 811:21-30
4. Cone EJ, Zichterman A, Heltsley R, Black DL, Cawthorn B, Robert T, Moser F, Caplan YH (2010) Urine testing for norcodeine, norhydrocodone and noroxycodone facilitates interpretation and reduces false negatives. Forensic Sci Int 198:58-61
5. Oyler JM, Cone EJ, Huestis MA (2000) Identi fi cation of hydrocodone in human urine following controlled codeine administration. J Anal Toxicol 24:530-535
6. Wasan AJ, Michna E, Janfaza D, Green fi eld S, Teter CJ, Jamison RN (2008) Interpreting urine drug tests: prevalence of morphine metabolism to hydromorphone in chronic pain patients treated with morphine. Pain Med 9:918-923
7. West R, Crews B, Mikel C, Almazon P, Latyshev S, Pesce A, West C (2009) Anomalous observations of codeine in patients on morphine. Ther Drug Monit 31:776-778
8. Mallet CR, Lu Z, Mazzeo JR (2004) A study of ion suppression effects in electrospray ionization from mobile phase additives and solidphase extracts. Rapid Commun Mass Spectrom 18:49-58
9. Taylor PJ (2005) Matrix effects: the Achilles heel of quantitative high-performance liquid chromatography-electrospray-tandem mass spectrometry. Clin Biochem 38:328-334
10. Tiller PR, Romanyshyn LA, Neue UD (2003) Fast LC/MS in the analysis of small molecules. Anal Bioanal Chem 377:788-802
11. Hsieh Y, Korfmacher WA (2006) Increasing speed and throughput when using HPLC-MS/MS systems for drug metabolism and pharmacokinetic screening. Curr Drug Metab 7:479-489
12. Hopfgartner G, Husser C, Zell M (2002) High-throughput quanti fi cation of drugs and their metabolites in biosamples by LC/MS/MS and CE-MS/MS: possibilities and limitations. Ther Drug Monit 24:134-143
13. Fox EJ, Twigger S, Allen KR (2009) Criteria for opiate identi fi cation using liquid chromatography linked to tandem mass spectrometry: problems in routine practice. Ann Clin Biochem 46:50-57
14. Eichhorst JC, Etter ML, Rousseaux N, Lehotay DC (2009) Drugs of abuse testing by tandem mass spectrometry: a rapid, simple method to replace immunoassays. Clin Biochem 42: 1531-1542